Document Detail


Family members of patients with sporadic medullary thyroid carcinoma must be screened for hereditary disease.
MedLine Citation:
PMID:  1455309     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Medullary thyroid carcinoma (MTC), a tumor arising from calcitonin-secreting C cells, appears in either a sporadic nonfamilial or a hereditary form as a component of a multiple endocrine neoplasia syndrome or familial non-multiple endocrine neoplasia MTC. Screening kindred of a patient with familial MTC to detect MTC in the early curable state is standard practice. Opinions conflict about whether it is necessary to screen relatives of patients with apparently nonfamilial MTC to exclude hereditary disease or whether the clinicopathologic features can differentiate between the two forms. METHODS: Clinically well kindred of a patient with MTC that was histopathologically characteristic of the sporadic type were screened for hereditary disease by measurement of plasma levels of basal and stimulated calcitonin. RESULTS: Three of four immediate relatives tested positive for excessive calcitonin secretion and underwent thyroidectomy. All had C-cell hyperplasia, the premalignant phase of MTC. CONCLUSIONS: The patient with apparently sporadic (nonfamilial) MTC was clearly an index case of familial disease. We conclude that clinical presentation and histopathologic examination are not adequate to reliably exclude hereditary MTC. Until genetic markers are readily available to distinguish between sporadic and familial forms, biochemical screening should be done in primary relatives of all patients with newly detected MTC.
Authors:
J E Olson; J Hughes; H D Alpern
Related Documents :
21527219 - Nephrectomy for hypertension in pediatric patients with a unilateral poorly functioning...
9630179 - C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for s...
17244789 - Thyroglobulin gene mutations producing defective intracellular transport of thyroglobul...
2894239 - Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. a french co...
707039 - Thyroiditis in myasthenia gravis.
12124869 - Increased prevalence of familial autoimmunity in simplex and multiplex families with ju...
23264359 - Treatment to lipid targets in patients with inflammatory joint diseases in a preventive...
21378249 - Alterations in circulating fatty acid composition in patients with systemic lupus eryth...
21641279 - Helicobacter pylori genotypes and types of gastritis in first-degree relatives of gastr...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Surgery     Volume:  112     ISSN:  0039-6060     ISO Abbreviation:  Surgery     Publication Date:  1992 Dec 
Date Detail:
Created Date:  1993-01-04     Completed Date:  1993-01-04     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1074-8; discussion 1078-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Mary Imogene Bassett Hospital, Cooperstown, NY 13326.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Calcitonin / secretion
Carcinoma / genetics*,  pathology,  secretion
Female
Genetic Testing*
Humans
Lymph Node Excision
Male
Middle Aged
Thyroid Neoplasms / genetics*,  pathology,  secretion
Thyroidectomy
Chemical
Reg. No./Substance:
9007-12-9/Calcitonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bombesin stimulates growth of human gastrinoma.
Next Document:  Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger R...